Compile Data Set for Download or QSAR
Report error Found 50 Enz. Inhib. hit(s) with all data for entry = 50032579
TargetGlutamate receptor 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50331367(N-((3R,4R)-1-ethyl-4-(3'-(methylsulfonamido)biphen...)
Affinity DataEC50:  1.60E+3nMAssay Description:Positive modulation of human GluA2 flip receptor by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetGlutamate receptor 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50331391(N-((3S,4S)-4-(4-(thiophen-3-yl)phenyl)tetrahydrofu...)
Affinity DataEC50:  400nMAssay Description:Positive modulation of human GluA2 flip receptor by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetGlutamate receptor 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50331390(N-((3S,4S)-4-(4-(thiophen-2-yl)phenyl)tetrahydrofu...)
Affinity DataEC50:  300nMAssay Description:Positive modulation of human GluA2 flip receptor by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetGlutamate receptor 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50331389(N-((3S,4S)-4-(4-(5-fluoropyridin-2-yl)phenyl)tetra...)
Affinity DataEC50:  300nMAssay Description:Positive modulation of human GluA2 flip receptor by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetGlutamate receptor 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50331388(N-((3S,4S)-4-(4-(5-fluoropyridin-3-yl)phenyl)tetra...)
Affinity DataEC50:  300nMAssay Description:Positive modulation of human GluA2 flip receptor by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetGlutamate receptor 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50331387(N-((3S,4S)-4-(4-(6-fluoropyridin-3-yl)phenyl)tetra...)
Affinity DataEC50:  300nMAssay Description:Positive modulation of human GluA2 flip receptor by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetGlutamate receptor 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50331386(N-((3S,4S)-4-(3'-acetylbiphenyl-4-yl)tetrahydrofur...)
Affinity DataEC50:  100nMAssay Description:Positive modulation of human GluA2 flip receptor by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetGlutamate receptor 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50331385(N-((3S,4S)-4-(4'-cyanobiphenyl-4-yl)tetrahydrofura...)
Affinity DataEC50:  500nMAssay Description:Positive modulation of human GluA2 flip receptor by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetGlutamate receptor 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50331384(N-((3R,4R)-1-methyl-4-(4-(thiophen-3-yl)phenyl)pyr...)
Affinity DataEC50:  3.20E+3nMAssay Description:Positive modulation of human GluA2 flip receptor by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetGlutamate receptor 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50331383(N-((3R,4R)-1-methyl-4-(4-(thiophen-2-yl)phenyl)pyr...)
Affinity DataEC50:  2.00E+4nMAssay Description:Positive modulation of human GluA2 flip receptor by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetGlutamate receptor 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50331382(N-((3R,4R)-4-(4-(6-fluoropyridin-3-yl)phenyl)-1-ph...)
Affinity DataEC50:  4.00E+3nMAssay Description:Positive modulation of human GluA2 flip receptor by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetGlutamate receptor 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50331381(N-((3R,4R)-4-(4-(6-fluoropyridin-3-yl)phenyl)-1-me...)
Affinity DataEC50:  5.00E+3nMAssay Description:Positive modulation of human GluA2 flip receptor by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetGlutamate receptor 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50331380(N-((3R,4R)-4-(4-(2-fluoropyridin-3-yl)phenyl)-1-me...)
Affinity DataEC50:  2.50E+3nMAssay Description:Positive modulation of human GluA2 flip receptor by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetGlutamate receptor 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50331378(N-((3R,4R)-4-(2'-fluorobiphenyl-4-yl)-1-methylpyrr...)
Affinity DataEC50:  2.50E+3nMAssay Description:Positive modulation of human GluA2 flip receptor by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetGlutamate receptor 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50331377(N-((3R,4R)-1-methyl-4-(3'-(trifluoromethyl)bipheny...)
Affinity DataEC50:  7.94E+4nMAssay Description:Positive modulation of human GluA2 flip receptor by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetGlutamate receptor 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50331376(N-((3R,4R)-4-(3'-acetylbiphenyl-4-yl)-1-methylpyrr...)
Affinity DataEC50:  6.30E+3nMAssay Description:Positive modulation of human GluA2 flip receptor by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetGlutamate receptor 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50331375(N-(4'-((3R,4R)-1-methyl-4-(1-methylethylsulfonamid...)
Affinity DataEC50:  4.00E+3nMAssay Description:Positive modulation of human GluA2 flip receptor by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetGlutamate receptor 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50331374(N-((3R,4R)-1-methyl-4-(3'-(methylsulfonyl)biphenyl...)
Affinity DataEC50:  5.00E+3nMAssay Description:Positive modulation of human GluA2 flip receptor by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetGlutamate receptor 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50331373(N-((3R,4R)-4-(4'-cyanobiphenyl-4-yl)-1-phenylpyrro...)
Affinity DataEC50:  6.20E+3nMAssay Description:Positive modulation of human GluA2 flip receptor by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetGlutamate receptor 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50331372(N-((3R,4R)-4-(4'-cyanobiphenyl-4-yl)-1-isopropylpy...)
Affinity DataEC50:  2.00E+4nMAssay Description:Positive modulation of human GluA2 flip receptor by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetGlutamate receptor 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50331371(N-((3R,4R)-4-(4'-cyanobiphenyl-4-yl)-1-ethylpyrrol...)
Affinity DataEC50:  7.90E+3nMAssay Description:Positive modulation of human GluA2 flip receptor by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetGlutamate receptor 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50331370(N-((3R,4R)-4-(4'-cyanobiphenyl-4-yl)-1-methylpyrro...)
Affinity DataEC50:  5.00E+3nMAssay Description:Positive modulation of human GluA2 flip receptor by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetGlutamate receptor 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50331369(N-((3R,4R)-4-(3'-(methylsulfonamido)biphenyl-4-yl)...)
Affinity DataEC50:  5.00E+3nMAssay Description:Positive modulation of human GluA2 flip receptor by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetGlutamate receptor 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50331368(N-((3R,4R)-1-isopropyl-4-(3'-(methylsulfonamido)bi...)
Affinity DataEC50:  6.30E+3nMAssay Description:Positive modulation of human GluA2 flip receptor by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetGlutamate receptor 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50331366(N-((3R,4R)-1-methyl-4-(3'-(methylsulfonamido)biphe...)
Affinity DataEC50:  300nMAssay Description:Positive modulation of human GluA2 flip receptor by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetGlutamate receptor 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50331379(N-((3R,4R)-1-methyl-4-(4-(pyridin-3-yl)phenyl)pyrr...)
Affinity DataEC50:  4.00E+3nMAssay Description:Positive modulation of human GluA2 flip receptor by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50331382(N-((3R,4R)-4-(4-(6-fluoropyridin-3-yl)phenyl)-1-ph...)
Affinity DataIC50: 80nMAssay Description:Displacement of [3H]-dofetilide from human hERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50331371(N-((3R,4R)-4-(4'-cyanobiphenyl-4-yl)-1-ethylpyrrol...)
Affinity DataIC50: 400nMAssay Description:Displacement of [3H]-dofetilide from human hERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50331373(N-((3R,4R)-4-(4'-cyanobiphenyl-4-yl)-1-phenylpyrro...)
Affinity DataIC50: 800nMAssay Description:Displacement of [3H]-dofetilide from human hERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50331381(N-((3R,4R)-4-(4-(6-fluoropyridin-3-yl)phenyl)-1-me...)
Affinity DataIC50: 1.00E+3nMAssay Description:Displacement of [3H]-dofetilide from human hERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50331369(N-((3R,4R)-4-(3'-(methylsulfonamido)biphenyl-4-yl)...)
Affinity DataIC50: 1.30E+3nMAssay Description:Displacement of [3H]-dofetilide from human hERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50331370(N-((3R,4R)-4-(4'-cyanobiphenyl-4-yl)-1-methylpyrro...)
Affinity DataIC50: 2.00E+3nMAssay Description:Displacement of [3H]-dofetilide from human hERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50331367(N-((3R,4R)-1-ethyl-4-(3'-(methylsulfonamido)biphen...)
Affinity DataIC50: 2.50E+3nMAssay Description:Displacement of [3H]-dofetilide from human hERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50331377(N-((3R,4R)-1-methyl-4-(3'-(trifluoromethyl)bipheny...)
Affinity DataIC50: 4.00E+3nMAssay Description:Displacement of [3H]-dofetilide from human hERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50331384(N-((3R,4R)-1-methyl-4-(4-(thiophen-3-yl)phenyl)pyr...)
Affinity DataIC50: 4.00E+3nMAssay Description:Displacement of [3H]-dofetilide from human hERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50331380(N-((3R,4R)-4-(4-(2-fluoropyridin-3-yl)phenyl)-1-me...)
Affinity DataIC50: 6.30E+3nMAssay Description:Displacement of [3H]-dofetilide from human hERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50331368(N-((3R,4R)-1-isopropyl-4-(3'-(methylsulfonamido)bi...)
Affinity DataIC50: 6.30E+3nMAssay Description:Displacement of [3H]-dofetilide from human hERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50331376(N-((3R,4R)-4-(3'-acetylbiphenyl-4-yl)-1-methylpyrr...)
Affinity DataIC50: 7.90E+3nMAssay Description:Displacement of [3H]-dofetilide from human hERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50331387(N-((3S,4S)-4-(4-(6-fluoropyridin-3-yl)phenyl)tetra...)
Affinity DataIC50: 1.26E+4nMAssay Description:Displacement of [3H]-dofetilide from human hERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50331375(N-(4'-((3R,4R)-1-methyl-4-(1-methylethylsulfonamid...)
Affinity DataIC50: 1.26E+4nMAssay Description:Displacement of [3H]-dofetilide from human hERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50331385(N-((3S,4S)-4-(4'-cyanobiphenyl-4-yl)tetrahydrofura...)
Affinity DataIC50: 1.26E+4nMAssay Description:Displacement of [3H]-dofetilide from human hERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50331366(N-((3R,4R)-1-methyl-4-(3'-(methylsulfonamido)biphe...)
Affinity DataIC50: 3.16E+4nMAssay Description:Displacement of [3H]-dofetilide from human hERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50331379(N-((3R,4R)-1-methyl-4-(4-(pyridin-3-yl)phenyl)pyrr...)
Affinity DataIC50: 3.16E+4nMAssay Description:Displacement of [3H]-dofetilide from human hERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50331383(N-((3R,4R)-1-methyl-4-(4-(thiophen-2-yl)phenyl)pyr...)
Affinity DataIC50: 6.30E+4nMAssay Description:Displacement of [3H]-dofetilide from human hERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50331386(N-((3S,4S)-4-(3'-acetylbiphenyl-4-yl)tetrahydrofur...)
Affinity DataIC50: 6.30E+4nMAssay Description:Displacement of [3H]-dofetilide from human hERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50331374(N-((3R,4R)-1-methyl-4-(3'-(methylsulfonyl)biphenyl...)
Affinity DataIC50: 6.30E+4nMAssay Description:Displacement of [3H]-dofetilide from human hERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50331388(N-((3S,4S)-4-(4-(5-fluoropyridin-3-yl)phenyl)tetra...)
Affinity DataIC50: 6.30E+4nMAssay Description:Displacement of [3H]-dofetilide from human hERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50331389(N-((3S,4S)-4-(4-(5-fluoropyridin-2-yl)phenyl)tetra...)
Affinity DataIC50: 6.30E+4nMAssay Description:Displacement of [3H]-dofetilide from human hERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50331390(N-((3S,4S)-4-(4-(thiophen-2-yl)phenyl)tetrahydrofu...)
Affinity DataIC50: 6.30E+4nMAssay Description:Displacement of [3H]-dofetilide from human hERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50331391(N-((3S,4S)-4-(4-(thiophen-3-yl)phenyl)tetrahydrofu...)
Affinity DataIC50: 6.30E+4nMAssay Description:Displacement of [3H]-dofetilide from human hERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2011
Entry Details Article
PubMed